Extracellular matrix collagen fibrils and myofascial connective tissue

Extracellular matrix (ECM) collagen fibrils and myofascial connective tissue constitute the primary structural scaffold of the human body, providing mechanical stability and facilitating force transmission between muscles and bones (Source: Nature Reviews Molecular Cell Biology). Collagen fibrils, predominantly composed of Type I and Type III collagen, are essential for tissue integrity and serve as ligands for integrin receptors, influencing cell behavior and wound healing (Source: UniProt). Myofascial tissue specifically surrounds and penetrates muscles, playing a key role in mechanotransduction and musculoskeletal health (Source: Journal of Anatomy). Pathological alterations in these structures, such as excessive collagen deposition (fibrosis) or abnormal cross-linking, are central to diseases like Dupuytren's contracture, scleroderma, and myofascial pain syndrome (Source: StatPearls). Therapeutic interventions often focus on the enzymatic degradation of collagen (e.g., collagenase) or the inhibition of signaling pathways that drive myofibroblast activation and subsequent ECM remodeling (Source: FDA).

Other names

FasciaConnective tissue matrixCollagenous stromaIntercellular matrix

Enzymatic degradation of collagen fibers and inhibition of TGF-beta signaling pathways to reduce collagen synthesis and myofibroblast activity (Source: PubChem, FDA).